Figure 5.
PG-AEBSF produced a dose-dependent inhibition of NADPH oxidase-mediated vascular superoxide production (represented by lucigenin-enhanced chemiluminescence). DPI, a nonselective NADPH inhibitor, 5 µM. **P<0.01; *P<0.05.
Abbreviations: PG-AEBSF, poly-l-glutamic acid-4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride; NADPH, nicotinamide adenine dinucleotide phosphate; DPI, diphenyleneiodonium chloride.